During the past decade, Montefiore Medical Center Moses conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Montefiore Medical Center Moses" #1 sponsor was "Massachusetts General Hospital" with 2 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials sponsored, "Abiomed Inc." with 1 trials sponsored, "Emory University" with 1 trials sponsored and "Montefiore Medical Center" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Montefiore Medical Center Moses" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 3 trials as a collaborator, "AIDS Clinical Trials Group" with 2 trials as a collaborator, "Cardiothoracic Surgical Trials Network (CTSN)" with 2 trials as a collaborator, "International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)" with 2 trials as a collaborator and "Kirby Institute" with 2 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Montefiore Medical Center Moses" are "Covid19" (2 trials), "Sepsis" (2 trials), "Acute Respiratory Distress Syndrome" (1 trials), "Acute Respiratory Infection" (1 trials) and "Coronary Artery Disease" (1 trials). Many other conditions were trialed in "Montefiore Medical Center Moses" in a lesser frequency.

Most popular intervention types in "Montefiore Medical Center Moses" are "Drug" (6 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Remdesivir" (2 trials), "5% Dextrose (room temperature)" (1 trials), "5% Dextrose refrigerated" (1 trials) and "AZD7442" (1 trials). Other intervention names were less common.

The vast majority of trials in "Montefiore Medical Center Moses" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Montefiore Medical Center Moses". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Montefiore Medical Center Moses, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Montefiore Medical Center Moses, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".